Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation
JF Morrison, PC Jones… - European Respiratory …, 1992 - Eur Respiratory Soc
In steroid resistant chronic obstructive pulmonary disease (COPD) we assessed the effect of
qid domiciliary nebulized fenoterol (F) 1.25 mg and ipratropium (I) 0.5 mg for three weeks in …
qid domiciliary nebulized fenoterol (F) 1.25 mg and ipratropium (I) 0.5 mg for three weeks in …
Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy
JM Goldman, C Teale, MF Muers - Respiratory medicine, 1992 - Elsevier
One-hundred nebulizer trials were performed in 98 adult patients with chronic airflow
limitation who had remained symptomatic despite regular use of bronchodilators by metered …
limitation who had remained symptomatic despite regular use of bronchodilators by metered …
The role of domiciliary nebulizers in managing patients with severe COPD
N Eiser, K Angus, S McHale - Respiratory medicine, 2001 - Elsevier
The difficulty of assessing nebulizer responses in chronic obstructive pulmonary disease
(COPD) has been demonstrated before. This study aims to re-examine both the role of …
(COPD) has been demonstrated before. This study aims to re-examine both the role of …
Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy
C Teale, JFJ Morrison, PC Jones, MF Muers - Respiratory medicine, 1991 - Elsevier
The role of short-term tests of reversibility in selecting patients with COAD for long-term
nebuliser therapy is uncertain. In a double-blind placebo-controlled crossover study we …
nebuliser therapy is uncertain. In a double-blind placebo-controlled crossover study we …
Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility
ER Bleecker, A Emmett, G Crater, K Knobil… - Pulmonary pharmacology …, 2008 - Elsevier
This retrospective analysis of data from two multi-center, randomized, double-blind, parallel
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …
Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil® AerolizerTM) with salbutamol (VentodiskTM)
D Benhamou, A Cuvelier, JF Muir, V Leclerc… - Respiratory …, 2001 - Elsevier
Formoterol fumarate is a β2-agonist bronchodilator that combines a fast onset of action with
a long duration of action. Its fast onset of action is well documented in asthma but has not …
a long duration of action. Its fast onset of action is well documented in asthma but has not …
Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
NM Eiser, C Phillips, PA Wooler - Respiratory medicine, 2001 - Elsevier
Spacing devices improve lung deposition of aerosols from metered dose inhalers (MDI) but
it is sometimes difficult for dyspnoeic patients to perform maximal breaths with breath-holds …
it is sometimes difficult for dyspnoeic patients to perform maximal breaths with breath-holds …
Faster Onset of Bronchodilation with Formoterol than with Salmeterol in Patients with Stable, Moderate‐Severe Copd: Results of a Randomized, Double‐Blind Clinical …
J Kottakis, GD Cioppa, J Creemers… - Canadian respiratory …, 2002 - Wiley Online Library
OBJECTIVES: To compare the onset and magnitude of bronchodilation after dry powder
inhalations of formoterol fumarate (Foradil Aerolizer) versus salmeterol xinofoate (Serevent …
inhalations of formoterol fumarate (Foradil Aerolizer) versus salmeterol xinofoate (Serevent …
Bronchodilator responsiveness in patients with COPD
The degree of acute improvement in spirometric indices after bronchodilator inhalation
varies among chronic obstructive pulmonary disease (COPD) patients, and depends upon …
varies among chronic obstructive pulmonary disease (COPD) patients, and depends upon …
Terbutaline in COPD comparison between Turbuhaler® and chlorofluorocarbon (CFC) inhaler
H Formgren, Å Sjökvist, E Ståhl, JE Wiren - Lung, 1994 - Springer
Patients with chronic obstructive pulmonary disease (COPD) often subjectively benefit from
inhaled R2-agonists in spite of little or no demonstrable effect in forced expiratory volume in …
inhaled R2-agonists in spite of little or no demonstrable effect in forced expiratory volume in …